Acute GVHD

9 clinical trials · Condition

Record	Firm	Date
A Study of Itolizumab in Combination With Corticosteroids for the First-Line Treatment of Acute Graft Versus Host Disease (EQUATOR) (NCT05263999)	Equillium	2022-04-29
Tacrolimus in Allogeneic Hematopoietic Stem Cell Transplant (HCT) (NCT04645667)	UNC Lineberger Comprehensive Cancer Center	2021-02-01
Prebiotic Galacto-oligosaccharide and Acute GVHD (NCT04373057)	University of Kansas Medical Center	2021-01-22
Ruxolitinib and Steroid As First Line Therapy for Acute GVHD (NCT03701698)	Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine	2018-11-01
A Study to Evaluate Steroid-free Treatment for Standard-Risk aGVHD (BMT CTN 1501) (NCT02806947)	Medical College of Wisconsin	2016-10-01
Dendritic Cells in Patients With Acute or Chronic Skin Graft Versus Host Disease (NCT02611180)	Washington University School of Medicine	2015-04-30
Photochemotherapy and Graft-versus-leukemia in Acute-leukemia (NCT02631993)	Karolinska University Hospital	2014-10-01
Exploratory Safety Study of ALD518 in Subjects With Steroid-refractory Acute Graft Versus Host Disease (GVHD) (NCT01530256)	CSL Behring	2012-03-01
Sirolimus & Mycophenolate Mofetil as GVHD Prophylaxis in Myeloablative, Matched Related Donor HCT (NCT00350181)	Stanford University	2006-08-01

Every clearance here is in the API, with alerts when new ones post.